NCT04211649View on ClinicalTrials.gov

Comparing Two Antibiotic Therapy Periods (3 Versus 7 Days) in Patients With Mild Leptospirosis and Seen at the Hospital in 5 French Overseas Departments (Martinique, Guadeloupe, French Guiana, Reunion, Mayotte)

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 1, 2027

Study Completion Date

February 1, 2028

Conditions
Mild Leptospirosis
Interventions
DRUG

3 days of antibiotherapy

Reduce at 3 days of antibiotherapy for the treatment of mild leptospirosis

Trial Locations (5)

97159

University Hospital of Guadeloupe, Pointe-à-Pitre

97200

Centre Hospitalier Universitaire de Martinique, Fort-de-France

97300

Centre Hospitalier Andrée Rosemond (CH de Cayenne), Cayenne

97448

Centre Hospitalier Universitaire Sud Réunion, Saint-Pierre

97600

Centre Hospitalier de Mayotte, Mamoudzou

All Listed Sponsors
collaborator

University Hospital of Guadeloupe

UNKNOWN

collaborator

Centre Hospitalier de Cayenne

OTHER

collaborator

Centre Hospitalier Universitaire de la Réunion

OTHER

collaborator

Hôpital de Mayotte

UNKNOWN

lead

University Hospital Center of Martinique

OTHER

NCT04211649 - Comparing Two Antibiotic Therapy Periods (3 Versus 7 Days) in Patients With Mild Leptospirosis and Seen at the Hospital in 5 French Overseas Departments (Martinique, Guadeloupe, French Guiana, Reunion, Mayotte) | Biotech Hunter | Biotech Hunter